P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 21 September 2019 | 9:42 am

Once-weekly somapacitan demonstrates similar one-year height gains compared to daily somatropin in a phase 2 trial in children with growth hormone deficiency

Vienna, Austria, 21 September 2019 - Novo Nordisk today announced that somapacitan, a novel growth hormone derivative in development as a once-weekly treatment option, more ...

Published 21 September 2019 | 12:59 am

Rybelsus® (semaglutide tablets), the first GLP-1 in a tablet approved in the US

Bagsværd, Denmark, 20 September 2019 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Rybelsus ® (semaglutide tablets), as more ...

Published 21 September 2019 | 12:37 am

Meet Alan Northrup

I'm inspired by the thrill of discovery...by the ability to help people. more ...

Published 21 September 2019 | 12:03 am

A Day in the Life: Leader of the Organization for Latino Achievement

Leticia Ferri grew up in a small town in Brazil with less than 20,000 residents. As a girl she never dreamed she'd work for an international company like Bristol-Myers Squibb and more ...

Published 20 September 2019 | 6:43 pm

Investor Update

Chugai obtained approval for additional indication and formulation for Tecentriq in PD-L1-positive triple negative breast cancer more ...

Published 20 September 2019 | 6:12 pm

Experts consider osteoporosis to be a silent epidemic which is neglected and under addressed, according to new survey released today

· Osteoporosis is estimated to affect 200 million people worldwide and results in a fracture every 3 seconds yet a new survey reveals bone specialists in Europe think its impact more ...

Published 20 September 2019 | 6:07 pm

Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases

Boehringer Ingelheim strengthens its retinal disease pipeline portfolio with new co-development and license agreement more ...

Published 20 September 2019 | 6:07 pm

Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health

The center will be one of the largest biotechnology production sites for veterinary vaccines in Europe more ...

Published 20 September 2019 | 4:57 pm

Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis

CHMP recommends approval of Dupixent ® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis more ...

Published 20 September 2019 | 2:13 pm

GSK receives positive CHMP opinion for intravenous Benlysta in children with lupus aged five years and above

GSK today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019

61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019